Publication:


abstract

OBJECTIVE:

To evaluate ischemia-modified albumin (IMA) in women who had been pregnant with a child suffering from neural tube defect.

STUDY DESIGN:

Samples from 50 women who had been pregnant with an affected child (25 spina bifida, 25 anencephaly) and 25 controls matched for age, gestational age, and body mass index were studied. We measured Serum IMA by enzyme-linked immunosorbent assay.

RESULTS:

Serum IMA was significantly higher in the study group compared to normal pregnancies (p < 0.05). The area under the receiver operating curve was 0.858 for IMA (95% CI, 0.769-0.947), whereas the optimal threshold value of IMA to discriminate between affected children and controls was 0.409 (sensitivity 88%, specificity 80%). The risk for increased IMA in mothers who have conceived a fetus with neural tube defect is 24.5 times higher than in the control group (rr = 24.5, 6.9-86.9, 95% CI) (p = 0.001).

CONCLUSION:

This study indicates that serum IMA in women who have conceived a fetus with neural tube defect is significantly higher than that in normal pregnant women.

Related Articles
Ischemia modified albumin in normal pregnancy and preeclampsia.
Hypertens Pregnancy. 2008
Ischemia modified albumin in normal pregnancy and preeclampsia.
van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Hypertens Pregnancy. 2008; 27(2):159-67.
The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies.
Acta Obstet Gynecol Scand. 2009
The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies.
Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. Acta Obstet Gynecol Scand. 2009; 88(4):479-82.
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Br J Obstet Gynaecol. 1995
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Chan A, Robertson EF, Haan EA, Ranieri E, Keane RJ. Br J Obstet Gynaecol. 1995 May; 102(5):370-6.
Review Blood folic acid and vitamin B12 in relation to neural tube defects.
Br J Obstet Gynaecol. 1996
Review Blood folic acid and vitamin B12 in relation to neural tube defects.
Wald NJ, Hackshaw AD, Stone R, Sourial NA. Br J Obstet Gynaecol. 1996 Apr; 103(4):319-24.
Review [Maternal age and neural tube defects: evidence for a greater effect in spina bifida than in anencephaly].
Rev Med Chil. 2005
Review [Maternal age and neural tube defects: evidence for a greater effect in spina bifida than in anencephaly].
Vieira AR, Castillo Taucher S. Rev Med Chil. 2005 Jan; 133(1):62-70. Epub 2005 Mar 10.